S. 4066 · 119th Congress (2025–2027)
Safeguarding Women from Chemical Abortion Act
A bill to provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.
CRS summary not yet available.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is S. 4066’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
- Sponsor
- Sen. Josh Hawley (R-MO)
- Cosponsors
7 cosponsors
0 original · 7 later
7 R
- Sen. John Cornyn (R-TX)· Later · Mar 12, 2026
- Sen. Marsha Blackburn (R-TN)· Later · Mar 18, 2026
- Sen. Ted Budd (R-NC)· Later · Mar 23, 2026
- Sen. Tommy Tuberville (R-AL)· Later · Mar 25, 2026
- Sen. Bernie Moreno (R-OH)· Later · Apr 15, 2026
- Sen. James Lankford (R-OK)· Later · Apr 20, 2026
- Sen. Mike Rounds (R-SD)· Later · Jun 23, 2026
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sources
- Congress.gov action
- Senate
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (2)
Safeguarding Women from Chemical Abortion Act
Display title, Short title · Introduced in Senate
A bill to provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.
Official title · Introduced in Senate